lenalidomide has been researched along with Carcinoma, Neuroendocrine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinen, Y; Fushiki, S; Horiike, S; Kiyota, M; Kobayashi, T; Kuroda, J; Maegawa, S; Mizutani, S; Nagoshi, H; Sasaki, N; Shimura, Y; Tando, S; Taniwaki, M; Tatekawa, S; Tsukamoto, T | 1 |
1 other study(ies) available for lenalidomide and Carcinoma, Neuroendocrine
| Article | Year |
|---|---|
Quadruple Cancers of Non-producing Multiple Myeloma, Cholangiocellular Carcinoma, and Two Different Thyroid Cancers.
Topics: Aged; Bile Duct Neoplasms; Bortezomib; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Cholangiocarcinoma; Humans; Lenalidomide; Male; Multiple Myeloma; Thalidomide; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |